MedPath

Investigation for the effects of hydrogen rich water on chronic hepatitis and liver cirrhosis

Not Applicable
Conditions
Chronic hepatitis and liver cirrhosis
Registration Number
JPRN-UMIN000010693
Lead Sponsor
Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences.Department of Gastroenterology and Hepatology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who need albumin administration more than once /week for 1 month or more. 2)Patients with edema or ascite. 3)Patients with hepatic encephalopathy. 4)Bilirubin levels equal or >2mg/dl. 5)Albumin levels <3g/dl. 6)Serum Na <130 mEq/L 7)Alcohol abuser. 8)Creatinin equal or >1.3mg/dl. 9)Patients who are receiving interferon treatment. 10)Family Doctors comment

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction of high ALT
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath